Compare STK & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STK | SIBN |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 688.8M | 778.8M |
| IPO Year | 2009 | 2018 |
| Metric | STK | SIBN |
|---|---|---|
| Price | $53.85 | $18.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $23.88 |
| AVG Volume (30 Days) | 41.2K | ★ 492.4K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,301,000.00 |
| Revenue This Year | N/A | $16.95 |
| Revenue Next Year | N/A | $14.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.53 |
| 52 Week Low | $32.50 | $11.48 |
| 52 Week High | $58.46 | $21.89 |
| Indicator | STK | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 65.63 | 52.96 |
| Support Level | $50.41 | $18.34 |
| Resistance Level | $55.53 | $19.35 |
| Average True Range (ATR) | 1.10 | 0.60 |
| MACD | 0.22 | -0.03 |
| Stochastic Oscillator | 99.28 | 51.37 |
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.